Clinical Trial

Safety and Efficacy of KSVCBD Injection in Autoimmune Diseases

Name: Safety and Efficacy of KSVCBD Injection in Autoimmune Diseases — clinical trial record (NCT07613411)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Early Phase 1

View on ClinicalTrials.gov →

Summary

KSVCBD injection is an in vivo Chimeric Antigen Receptor T-Cell (CAR-T cell) therapy product. This single-arm, open-label, early exploratory clinical study is designed to evaluate the safety and preliminary efficacy of KSVCBD injection in patients with Autoimmune Diseases.

Trial Details

NCT Number	NCT07613411
Lead Sponsor	Chinese PLA General Hospital
Conditions	Autoimmune Diseases
Enrollment	60 participants
Start Date	2026-06-01
Primary Completion	2028-12-31 (estimated)
Study Completion	2029-03-31 (estimated)
Updated on ClinicalTrials.gov	2026-05-29